Allergan confirmed on Thursday that it was in preliminary discussions to sell itself to Pfizer, potentially setting up a blockbuster merger of two drug makers as the industry undergoes an enormous wave of consolidation.
A takeover of Allergan, which manufactures Botox, would be the biggest deal of the year, given the company’s market value of $113 billion as of Thursday morning.
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant18
03:35 Ivan Rodriguez, Tim Raines and Jeff Bagwell prove Hall of Fame does forgive15
21:52 Netflix nears 94 million subscribers 10 years after streaming launch16
22:33 Allergan to pay $15 million over failing to disclose merger talks18